Organisation paid for research Program year 2024 Source: CMS Open Payments

Genesis Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$195,334

35 payments

Through program year 2024, Genesis Research, LLC is reported as receiving $195,334 in research payments, across 35 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$58,710	11
2023	Research	$126,936	15
2022	Research	$9,688	9

Breakdown

Who paid Research payments · program years 2022–2024

Ortho-Clinical Diagnostics, Inc. $165,011 23 payments
Axonics Modulation Technologies, Inc. $27,180 3 payments
Urogen Pharma, Inc. $3,143 9 payments

Studies the money was for Research payments · program years 2022–2024

VITROS Immunodiagnostic Products Total PSA III Aid in Management Intended Use Sample Collection $101,096 14 payments
VITROS Immunodiagnostic Products Total PSA III Aid in Detection Intended Use Sample Collection $63,915 9 payments
Foramen Finder Study $27,180 3 payments
Urogen Pharma Bl011 $2,688 8 payments
Bl011 - A Phase 3 Single-Arm Study of Ugn -102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (Envision) $455 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.